Characterization of the rat mesangial cell type 2 sulfonylurea receptor

Kidney International

Volumn 55, Issue 6, 1999, Pages 2289-2298

  Asano, Kenichiro ^a   Cortes, Pedro ^a   Garvin, Jeffrey L ^a   Riser, Bruce L ^a   Rodríguez Barbero, Alicia ^a   Szamosfalvi, Balázs ^a   Jerry, Yee ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Glibenclamide; Glucose uptake; Hypoglycemia; Mesangial cell contraction; Non insulin dependent diabetes; Tolazamide

Indexed keywords

GLIBENCLAMIDE; SULFONYLUREA RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; MESANGIUM CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR DENSITY; TISSUE DISTRIBUTION;

EID: 0033064841     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00485.x     Document Type: Article

References (55)

1. 1. Peters AL, Davidson MB: Diabetes mellitus in the elderly: Use of sulfonylurea agents in older diabetic patients. Clin Geriatr Med 6:903-921, 1990
2. 2. University Group Diabetes Program: A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. I. Design, methods, and baseline results. Dia-betes 19:747-783, 1970
3. 3. Ashcroft SJH, Ashcroft FM: The sulfonylurea receptor. Biochim Biophys Acta 1175:45-59, 1992
4. 3H1 myocytes. Diabetes 39:1399-1407, 1990
5. 5. Tordjman KM, Leingang KA, James DF, Mueckler MM: Differential regulation of two distinct glucose transporter species expressed in 3T3-L1 adipocytes: Effect of chronic insulin and tolbutamide treatment. Proc Natl Acad Sci USA 86:7761-7765, 1989
6. 6. Martz A, Jo I, Jung CY: Sulfonylurea binding to adipocyte membranes and potentiation of insulin-stimulated hexose transport. J Biol Chem 264:13672-13678, 1989
7. 7. Aguilar-Bryan L, Nelson DA, Vu QA, Humphrey MB, Boyd AE III: Photoaffinity labeling and partial purification of the β cell sulfonylurea receptor using a novel, biologically active glyburide analog. J Biol Chem 265:8218-8224, 1990
8. + channels. Neuron 16:1011-1017, 1996
9. 9. Panten U, Burgfeld J, Goerke F, Rennicke M, Schwanstecher M, Wallasch A, Zünkler BJ, Lenzen S: Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Biochem Pharmacol 38:1217-1229, 1989
10. ATP channel as a receptor for potassium channel openers. J Biol Chem 271:8796-8799, 1996
11. 11. Ämmälä C, Moorhouse A, Gribble F, Ashfield R, Proks P, Smith PA, Sakura H, Coles B, Ashcroft SJH, Ashcroft FM: Promiscuous coupling between the sulfonylurea receptor and inwardly rectifying potassium channels. Nature 379:545-548, 1996
12. 12. Edwards G, Weston AH: The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol 33:597-637, 1993
13. 13. Peyrollier K, Héron L, Virsolvy-Vergine A, Le Cam A, Bataille D: α Endosulfine is a novel molecule, structurally related to a family of phosphoproteins. Biochem Biophys Res Commun 223:583-586, 1996
14. 14. Virsolvy-Vergine A, Leray H, Kuroki S, Lupo B, Dufour M, Bataille D: Endosulphine, an endogenous peptidic ligand for the sulfonylurea receptor: Purification and partial characterization from ovine brain. Proc Natl Acad Sci USA 89:6629-6633, 1992
15. 15. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JPIV, Boyd AE III, Gonzälez G, Herrera-Sosa H, Nguy K, Bryan J, Nelson DA: Cloning of the β cell high-affinity sulfonylurea receptor: A regulator of insulin secretion. Science 268:423-425, 1995
16. 16. Higgins CF: The ABC of channel regulation. Cell 82:693-696, 1995
17. 17. Henquin JC: Tolbutamide stimulation and inhibition of insulin release: Studies of the underlying ionic mechanisms in isolated rat islets. Diabetologia 18:151-160, 1980
18. 18. Dean PM, Matthews EK: Electrical activity in pancreatic islet cells. Nature 219:389-390, 1968
19. + channels. Science 268:372-373, 1995
20. ATP channels in hamster insulinoma tumor (HIT) cells. J Biol Chem 267:14934-14940, 1992
21. 21. Thomas PM, Cote GJ, Wohllk N, Haddad B, Mathew PM, Rabl W, Aguilar-Bryan L, Gagel RF, Bryan J: Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 268:426-429, 1995
22. 22. Dunne MJ, Kane C, Shepherd RM, Sanchez JA, James RF, Johnson PR, Aynsley-Green A, Lu S, Clement JP IV, Lindley KJ, Seino S, Aguilar-Bryan L: Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med 336:703-706, 1997
23. 23. Nestorowicz A, Wilson BA, Schoor KP, Inoue H, Glaser B, Landau H, Stanley CA, Thornton PS, Clement JP IV, Bryan J, Aguilar-Bryan L, Permutt MA: Mutations in the sulfonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Hum Mol Genet 5:1813-1822, 1996
24. ATP channels. Diabetes 45:1439-1445, 1996
25. 25. Zini S, Ben-Ari Y, Ashford MLJ: Characterization of sulfonylurea receptors and the action of potassium channel openers on cholinergic neurotransmission in guinea pig isolated small intestine. J Pharmacol Exp Ther 259:566-573, 1991
26. 26. Ho K, Nichols CG, Lederer WJ, Lytton J, Vassilev PM, Kanazirska MV, Hebert SC: Cloning and expression of an inwardly rectifying ATP-regulated potassium channel. Nature 362:31-37, 1993
27. 1 channel in thick ascending limb of rat kidney. Am J Physiol 267:F599-F605, 1994
28. 28. Cortes P, Riser BL, Asano K, Rodríguez-Barbero A, Narins RG, Yee J: Effects of oral antihyperglycemic agents on extracellular matrix synthesis by mesangial cells. Kidney Int 54:1995-1998, 1998
29. 29. Dumler F, Cortes P: Uracil ribonucleotide metabolism in rat and human glomerular epithelial and mesangial cells. Am J Physiol 255:C712-C718, 1988
30. 30. Heilig CW, Concepcion LA, Riser BL, Freytag SO, Zhu M, Cortes P: Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96:1802-1814, 1995
31. 31. Santerre RF, Cook RA, Crisel RMD, Sharp JD, Schmidt RJ, Williams DC, Wilson CP: Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells. Proc Natl Acad Sci USA 78:4339-4343, 1981
32. 32. Alvarez RJ, Sun MJ, Haverty TP, Iozzo RV, Meyers JC, NeilSon EG: Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines. Kidney Int 41:14-23, 1992
33. 33. Yee J, Kuncio GS, Bhandari B, Shihab FS, Neilson EG: Identification of promoter activity and differential expression of transcripts encoding the murine stromelysin-1 gene in renal cells. Kidney Int 52:120-129, 1997
34. 34. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
35. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450, 1985
36. 36. Whiteside C, Munk S, Zhou X, Miralem T, Templeton DM: Chelation of intracellular calcium prevents mesangial cell proliferative responsiveness. J Am Soc Nephrol 9:14-25, 1998
37. 37. Harris AK, Wild P, Stopak D: Silicone rubber substrata: A new wrinkle in the study of cell locomotion. Science 208:177-179, 1980
38. 38. Chrzanowska-Wodnicka M, Burridge K: Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol 133:1403-1415, 1996
39. 39. Singhal PC, Scharschmidt LA, Gibbons N, Hays RM: Contraction and relaxation of cultured mesangial cells on a silicone rubber surface. Kidney Int 30:862-873, 1986
40. 40. Anonymous: Tolazamide (Tolinase). Off Lit N Drugs 10:423-427, 1966
41. ATP channel complex. J Gen Physiol 110:655-664, 1997
42. ATP channel subunits. Neuron 18:827-838, 1997
43. KATP: An inward rectifier subunit plus the sulfonylurea receptor. Science 270:1166-1170, 1995
44. 44. Ho K: The ROMK-cystic fibrosis transmembrane conductance regulator connection: New insights into the relationship between ROMK and cystic fibrosis transmembrane conductance regulator channels. Curr Opin Nephrol Hypertens 7:49-58, 1998
45. 45. Munzenmaier DH, Greene AS: Angiotensin II mediates a sustained rise in nuclear and cytoplasmic calcium via multiple receptor subtypes. Am J Physiol 269:H565-H570, 1995
46. 3 receptor channels. Neuron 14:163-167, 1995
47. 47. Allbritton NL, Oancea E, Kuhn MA, Meyer T: Source of nuclear calcium signals. Proc Natl Acad Sci USA 91:12458-12462, 1994
48. 48. Gilchrist JS, Czubryt MP, Pierce GN: Calcium and calcium-binding proteins in the nucleus. Mol Cell Biochem 135:79-88, 1994
49. 2+] changes in nucleus and cytosol. Cell Calcium 16:239-246, 1994
50. 50. Menè P, Teti A, Pugliese F, Cinotti GA: Calcium release-activated calcium influx in cultured human mesangial cells. Kidney Int 46:122-128, 1994
51. 2+ release in agonist-stimulated AR42J cells. J Biol Chem 266:1363-1366, 1991
52. 2+ oscillation in AR42J cells. J Biol Chem 265:20856-20862, 1990
53. 53. Hajjar RJ, Bonventre JV: Oscillations of intracellular calcium induced by vasopressin in individual Fura-2-loaded mesangial cells. J Biol Chem 266:21589-21594, 1991
54. 54. Bollen M, Stalmans W: The structure, role, and regulation of type I protein phosphatases. Crit Rev Biochem Mol Biol 27:227-281, 1992
55. 55. Menè P, Pugliese G, Pricci F, Di Mario U, Cinotti GA, Pugliese F: High glucose inhibits cytosolic calcium signaling in cultured rat mesangial cells. Kidney Int 43:585-591, 1993